nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—TPO—Thyroxine (Thyroid Hormone) Production—TSHR—adrenal gland cancer	0.21	0.515	CbGpPWpGaD
Methimazole—CYP2C19—urine—adrenal gland cancer	0.099	0.167	CbGeAlD
Methimazole—TPO—adrenal gland—adrenal gland cancer	0.0809	0.137	CbGeAlD
Methimazole—CYP1A2—urine—adrenal gland cancer	0.0808	0.136	CbGeAlD
Methimazole—CYP2C9—urine—adrenal gland cancer	0.0767	0.13	CbGeAlD
Methimazole—CYP2E1—urine—adrenal gland cancer	0.0727	0.123	CbGeAlD
Methimazole—CYP3A4—urine—adrenal gland cancer	0.0585	0.0988	CbGeAlD
Methimazole—CYP2D6—urine—adrenal gland cancer	0.0576	0.0972	CbGeAlD
Methimazole—CYP2B6—adrenal cortex—adrenal gland cancer	0.0205	0.0346	CbGeAlD
Methimazole—CYP2A6—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0172	0.0421	CbGpPWpGaD
Methimazole—CYP2B6—gonad—adrenal gland cancer	0.017	0.0287	CbGeAlD
Methimazole—CYP2B6—adrenal gland—adrenal gland cancer	0.0148	0.025	CbGeAlD
Methimazole—CYP2E1—adrenal gland—adrenal gland cancer	0.0139	0.0235	CbGeAlD
Methimazole—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0129	0.0318	CbGpPWpGaD
Methimazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00847	0.0208	CbGpPWpGaD
Methimazole—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00762	0.0187	CbGpPWpGaD
Methimazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.00726	0.0178	CbGpPWpGaD
Methimazole—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00615	0.0151	CbGpPWpGaD
Methimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00585	0.0144	CbGpPWpGaD
Methimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00573	0.0141	CbGpPWpGaD
Methimazole—TPO—Metabolism—SDHB—adrenal gland cancer	0.00502	0.0123	CbGpPWpGaD
Methimazole—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00464	0.0114	CbGpPWpGaD
Methimazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00463	0.0114	CbGpPWpGaD
Methimazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00423	0.0104	CbGpPWpGaD
Methimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00403	0.0099	CbGpPWpGaD
Methimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00345	0.00846	CbGpPWpGaD
Methimazole—TPO—Metabolism—RRM1—adrenal gland cancer	0.00323	0.00793	CbGpPWpGaD
Methimazole—TPO—Metabolism—SDHD—adrenal gland cancer	0.00323	0.00793	CbGpPWpGaD
Methimazole—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00316	0.00775	CbGpPWpGaD
Methimazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00279	0.00685	CbGpPWpGaD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00266	0.00653	CbGpPWpGaD
Methimazole—CYP2A6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00256	0.00629	CbGpPWpGaD
Methimazole—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00255	0.00626	CbGpPWpGaD
Methimazole—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0025	0.00613	CbGpPWpGaD
Methimazole—CYP2A6—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00242	0.00594	CbGpPWpGaD
Methimazole—TPO—Metabolism—MED12—adrenal gland cancer	0.00241	0.00591	CbGpPWpGaD
Methimazole—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00207	0.00507	CbGpPWpGaD
Methimazole—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00203	0.00497	CbGpPWpGaD
Methimazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00193	0.00473	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.0018	0.00442	CbGpPWpGaD
Methimazole—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00178	0.00436	CbGpPWpGaD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00177	0.00435	CbGpPWpGaD
Methimazole—TPO—Metabolism—PRKACA—adrenal gland cancer	0.00176	0.00431	CbGpPWpGaD
Methimazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00176	0.00431	CbGpPWpGaD
Methimazole—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00162	0.00398	CbGpPWpGaD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00156	0.00383	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0015	0.00368	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00148	0.00363	CbGpPWpGaD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00144	0.00353	CbGpPWpGaD
Methimazole—TPO—Metabolism—GNAS—adrenal gland cancer	0.00143	0.0035	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00142	0.00349	CbGpPWpGaD
Methimazole—TPO—Metabolism—ABCB1—adrenal gland cancer	0.0014	0.00343	CbGpPWpGaD
Methimazole—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00139	0.0034	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	0.00136	0.00334	CbGpPWpGaD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00122	0.00299	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SDHB—adrenal gland cancer	0.00122	0.00299	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00116	0.00284	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.0011	0.00269	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.00108	0.00264	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00105	0.00258	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00105	0.00258	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.000982	0.00241	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.000962	0.00236	CbGpPWpGaD
Methimazole—TPO—Metabolism—POMC—adrenal gland cancer	0.00096	0.00235	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00094	0.0023	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.00083	0.00204	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000801	0.00196	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—RRM1—adrenal gland cancer	0.000784	0.00192	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SDHD—adrenal gland cancer	0.000784	0.00192	CbGpPWpGaD
Methimazole—TPO—Metabolism—PTGS2—adrenal gland cancer	0.000765	0.00188	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000763	0.00187	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000757	0.00186	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000742	0.00182	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00073	0.00179	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000683	0.00167	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000677	0.00166	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000647	0.00159	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.000633	0.00155	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.000633	0.00155	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000624	0.00153	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.00062	0.00152	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.00062	0.00152	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—MED12—adrenal gland cancer	0.000585	0.00143	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000584	0.00143	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.000578	0.00142	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000532	0.00131	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000499	0.00122	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000478	0.00117	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000478	0.00117	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000472	0.00116	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000462	0.00113	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000455	0.00112	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000446	0.00109	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.00044	0.00108	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.00044	0.00108	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000436	0.00107	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000436	0.00107	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	0.000427	0.00105	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000373	0.000914	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000373	0.000914	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000357	0.000875	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GNAS—adrenal gland cancer	0.000346	0.000848	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000344	0.000844	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	0.000339	0.000832	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000337	0.000827	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000328	0.000804	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000325	0.000798	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000319	0.000782	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000291	0.000713	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000288	0.000705	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000288	0.000705	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000279	0.000684	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000278	0.000681	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000274	0.000672	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000273	0.00067	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000268	0.000658	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.00026	0.000638	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000254	0.000624	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000248	0.000609	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000239	0.000587	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000237	0.000582	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—POMC—adrenal gland cancer	0.000233	0.000571	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000232	0.000569	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000214	0.000526	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000211	0.000517	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000207	0.000507	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000203	0.000497	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000198	0.000486	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000194	0.000476	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000192	0.000472	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.00019	0.000467	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000189	0.000463	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000188	0.000461	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	0.000186	0.000456	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000184	0.000451	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.000164	0.000403	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000161	0.000395	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000156	0.000384	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	0.00015	0.000368	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	0.000147	0.00036	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000142	0.000348	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000131	0.00032	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000129	0.000317	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000127	0.000311	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000124	0.000305	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000113	0.000278	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—POMC—adrenal gland cancer	0.000111	0.000271	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000104	0.000255	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000103	0.000253	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	8.82e-05	0.000216	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—POMC—adrenal gland cancer	8.53e-05	0.000209	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.81e-05	0.000167	CbGpPWpGaD
